In 2022, the global induced pluripotent stem cell (iPSC) market holds a value of US$ 1.8 Bn, and is predicted to rise at a high CAGR of 6.6% through 2026.
Rising demand for novel treatment therapies has led to an increase in medical research activities across the world. Stem cell research is one of the prime areas of focus, and hence, this increased research has favored demand for induced pluripotent stem cells.
Increasing investments from governments and rising prevalence of chronic diseases will further bolster iPSC market potential across the forecast period of 2022-2026. However, ethical concerns and high costs associated with stem cell research are expected to have a constraining effect on the global induced pluripotent stem cell industry through 2026.
Download Free Sample Copy of This Report – https://www.factmr.com/connectus/sample?flag=S&rep_id=7298
Induced pluripotent stem cell providers are focusing on the adoption of new strategies to increase their market presence and boost revenue generation.
- In April 2022, Ncardia, a leading name in contract research, announced the launch of a new business called Cellistic, which will be entirely focused on its iPSC expertise.
The world has witnessed an increase in the incidence of neurological disorders and the demand for novel treatments for the same is also high.
Key Takeaways from Market Study
- The induced pluripotent stem cell market in 2022 stands at US$ 1.8 Bn.
- From 2022 to 2026, demand for induced pluripotent stem cells is projected to surge at a CAGR of 6.6%.
- By 2026, the market is predicted to reach an approximate valuation of US$ 2.3 Bn.
- Increasing investments in research, growing establishment of contract research organizations, and rising prevalence of chronic diseases are factors that drive market potential.
- High costs of stem cell research and ethical concerns in research methodology are factors that could slow down market expansion.
- The market for induced pluripotent stem cells in the United States stands at a value of US$ 820.4 Mn.
- Consumption of induced pluripotent stem cells in China is projected to rise at a high CAGR of 8.5% from 2022 to 2026.
“Rising investments from governments to advance stem cell research are expected to favor market growth potential through 2026,” says a Fact.MR analyst
Get Customization on this Report for Specific Research Solutions – https://www.factmr.com/connectus/sample?flag=RC&rep_id=7298
Competitive Landscape:
Induced pluripotent stem cell suppliers are increasing their investments in research and development to advance their offerings in stem cell therapies which are gaining popularity for the treatment of multiple chronic diseases.
- In April 2022, TreeFrog Therapeutics, a biotechnology firm focused on making affordable stem cell therapies, announced the launch of a grant worth US$ 100,000. The Stem Cell SpaceShot Grant will be open to PhD-level scientists and students to advance stem cell biology research and promote scientific discoveries.
Key Companies Profiled
- Sumitomo Dainippon Pharma Co. Ltd.
- FUJIFILM Cellular Dynamics Inc.
- Ncardia
- REPROCELL USA Inc.
- Takara Bio Inc.
- Thermo Fisher Scientific Inc.
- Axol Bioscience Ltd.
- ViaCyte Inc.
- Cynata Therapeutics Limited
- Pluricell Biotech
- Evotec SE
- Fate Therapeutics Inc.
For In-Depth Competitive Analysis, Buy Now – https://www.factmr.com/checkout/7298
Key Segments Covered in Induced Pluripotent Stem Cell Industry Research
- by Cell Type :
- Vascular Cells
- Cardiac Cells
- Neuronal Cells
- Liver Cells
- Immune Cells
- Other Cell Types
- by Research Method :
- Cellular Reprogramming
- Cell Culture
- Cell Differentiation
- Cell Analysis
- Cellular Engineering
- Other Research Methods
- by Application :
- iPSC for Drug Development & Toxicology Testing
- iPSC for Academic Research
- iPSC for Regenerative Medicine
- Other Applications
- iPSC Market by Region :
- North America
- Latin America
- Europe
- East Asia
- South Asia & Oceania
- MEA
Check Out More Related Studies Published By Fact.MR Research:
Surgical Suction Pumps Market: Surgical suction pumps are used to dispatch gases and bodily fluids, tissue and surgical fluids during or after the surgery. Surgical suction pumps have a daily application in hospitals. Surgical suction pump is used for wound drainage suction, vacuum-assisted delivery, liposuction, laparoscopy, urology, and endoscopy and arthroscopy procedures.
Surgical Hand-Access Port Market: Surgical hand-access port acts as a gateway, and helps the surgeon to insert surgical instruments or hand at the site of surgery. Surgical hand-access port is majorly used in laparoscopic surgeries. Minimal invasion surgery can be performed and peritoneal gas pressure can be maintained with the help of surgical hand-access ports.
Surgical and Interventional Cardiology Devices Market: Numerous surgical and intervention procedures are performed for treatment of cardiovascular disorders. Surgical and interventional cardiology devices are designed to maintain the natural rhythm of heartbeats. Due to unhealthy life style and increasing geriatric population the rate of heart attacks and cardiovascular disorder has increased immensely in recent years. According to WHO 31% deaths worldwide is due to cardiovascular disorder.
Surgical Integration Systems Market: Surgical integration systems are specially designed operating rooms that are equipped with surgical instruments and medical equipment such as surgical lights, cameras, microscopes, air management devices and screen displays. Surgical integration systems are designed to simplify and streamline the operating room by consolidating data and access to video.
Surgical Catheters Market: A surgical catheter is a medical device of thin tube-shaped, which is generally used to perform various surgical procedures in order to treat chronic diseases. Surgical catheters are inserted into body cavities and are used for diagnostic and therapeutic purposes.
About Us:
Market research and consulting agency with a difference! That’s why 80% of Fortune 1,000 companies trust us for making their most critical decisions. While our experienced consultants employ the latest technologies to extract hard-to-find insights, we believe our USP is the trust clients have on our expertise. Spanning a wide range – from automotive & industry 4.0 to healthcare & retail, our coverage is expansive, but we ensure even the most niche categories are analyzed. Our sales offices in United States and Dublin, Ireland. Headquarter based in Dubai, UAE. Reach out to us with your goals, and we’ll be an able research partner.
Contact:
US Sales Office:
11140 Rockville Pike
Suite 400
Rockville, MD 20852
United States
Tel: +1 (628) 251-1583
Email: sales@factmr.com